CG
C2i Genomics
About
C2i Genomics is the first company to develop the most comprehensive whole-genome monitoring of cancer recurrence and progression by analyzing subtle changes in the pattern of the tumor’s DNA.
Tags
Total Employees
60
Current headcount
Company Timeline
Funding rounds, employee growth, revenue, and exits over the same period. News mentions shown as markers.
No timeline data for this period
Score Breakdown
57Traction
58Team
90Visibility
28Profile
80Community
15Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does C2i Genomics do?
C2i Genomics is the first company to develop the most comprehensive whole-genome monitoring of cancer recurrence and progression by analyzing subtle changes in the pattern of the tumor’s DNA.
How much funding has C2i Genomics raised?
C2i Genomics has raised a total of $112M in funding. The most recent round on record is Series B.
When was C2i Genomics founded?
C2i Genomics was founded in 2019.
What industry does C2i Genomics operate in?
C2i Genomics operates in Healthcare, Genomics, Cancer, Tumor Detection, DNA, Liquid Biopsy.
How many employees does C2i Genomics have?
C2i Genomics has approximately 60 people on record.
What is C2i Genomics's current status?
C2i Genomics's current operating status is: Acquired.